Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranes
- 6 April 1992
- journal article
- Published by Wiley in FEBS Letters
- Vol. 300 (3) , 232-236
- https://doi.org/10.1016/0014-5793(92)80852-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Glucagon‐like peptide‐1(7–36) amide is a new incretin/enterogastrone candidateEuropean Journal of Clinical Investigation, 1991
- Characterization of receptors for glucagon‐like peptide‐1(7–36) amide on rat lung membranesFEBS Letters, 1990
- Interaction of Glucagon-Like Peptide- 1 (7–36)amide and Somatostatin-14 in RINm5F Cells and in the Perfused Rat PancreasPancreas, 1989
- Effect of truncated glucagon‐like peptide 1 on cAMP in rat gastric glands and HGT‐1 human gastric cancer cellsFEBS Letters, 1988
- Effect of glucagon-like peptide-1 on insulin secretionRegulatory Peptides, 1988
- Receptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cellsJournal of Endocrinology, 1988
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANPublished by Elsevier ,1987
- Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.Journal of Clinical Investigation, 1987
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987
- The incretin concept todayDiabetologia, 1979